Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024)

Historic Dividends Paid - Common for Guided Therapeutics (GTHP) over the last 2 years, with Q1 2024 value amounting to $120120.0.

  • Guided Therapeutics' Dividends Paid - Common changed 0.0% to $120120.0 in Q1 2024 from the same period last year, while for Jun 2024 it was $120120.0, marking a year-over-year increase of 8396.23%. This contributed to the annual value of $65296.0 for FY2023, which is 4564.1% down from last year.
  • Guided Therapeutics' Dividends Paid - Common amounted to $120120.0 in Q1 2024, which was down 0.0% from -$54824.0 recorded in Q2 2023.
  • In the past 5 years, Guided Therapeutics' Dividends Paid - Common registered a high of $120120.0 during Q1 2023, and its lowest value of -$54824.0 during Q2 2023.